Category: Accuray Inc.
New Accuray president & CEO Joshua Levine plans to cut about 13% of the company's workers in efforts to execute a "strategic transformation" that will save the company about $40 million per year.
Sunnyvale, Calif.-based radiotherapy devices maker Accuray (NSDQ:ARAY) will lay off about 13% of its global workforce, mostly in the U.S., the company reported this week.
Accuray made the announcement upon releasing its preliminary 2nd quarter 2013 financial results, in which the company noted a 45%-50% decline in product revenue.
Radiotherapy devices maker Accuray settles a patent infringement claim from Radiation Stabilization Solutions for $150,000.
A drawing from Radiation Stabilization Solutions' patent.
Radiotherapy devices maker Accuray reports a 18% dive in 1st-quarter sales as the company comes down from previous spikes associated with a merger.
Accuray (NSDQ:ARAY) lost a little love on Wall Street after the company reported a sizable dive in sales for its 1st quarter 2013.
The FDA grants 510(k) clearance to Accuray's CyberKnife M6 radiosurgery device for treating cancerous tumors.
Accuray (NSDQ:ARAY) won 510(k) clearance from the FDA for the latest iteration of its CyberKnife radiosurgery device.
Chief commercial officer Kelly Londy told MassDevice.com that the Sunnyvale, Calif.-based medical device company is launching the product immediately.